دورية أكاديمية
Human gut Actinobacteria boost drug absorption by secreting P-glycoprotein ATPase inhibitors.
العنوان: | Human gut Actinobacteria boost drug absorption by secreting P-glycoprotein ATPase inhibitors. |
---|---|
المؤلفون: | Kyaw TS; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA., Zhang C; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA., Sandy M; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA.; Quantitative Metabolite Analysis Center, Benioff Center for Microbiome Medicine, University of California San Francisco, San Francisco, CA 94143, USA., Trepka K; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA., Zhang S; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA., Ramirez Hernandez LA; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA., Ramirez L; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA., Goh JJN; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA., Yu K; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA., Dimassa V; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA., Bess EN; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA., Brockert JG; Quantitative Metabolite Analysis Center, Benioff Center for Microbiome Medicine, University of California San Francisco, San Francisco, CA 94143, USA., Dumlao DS; Quantitative Metabolite Analysis Center, Benioff Center for Microbiome Medicine, University of California San Francisco, San Francisco, CA 94143, USA., Bisanz JE; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA., Turnbaugh PJ; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA.; Chan-Zuckerberg Biohub-San Francisco, San Francisco, CA 94158, USA. |
المصدر: | IScience [iScience] 2024 May 27; Vol. 27 (6), pp. 110122. Date of Electronic Publication: 2024 May 27 (Print Publication: 2024). |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: [Cambridge, MA] : Cell Press, [2018]- |
مستخلص: | Drug efflux transporters are a major determinant of drug efficacy and toxicity. A canonical example is P-glycoprotein (P-gp), an efflux transporter that controls the intestinal absorption of diverse compounds. Despite a rich literature on the dietary and pharmaceutical compounds that impact P-gp activity, its sensitivity to gut microbial metabolites remains an open question. Surprisingly, we found that the cardiac drug-metabolizing gut Actinobacterium Eggerthella lenta increases drug absorption in mice. Experiments in cell culture revealed that E. lenta produces a soluble factor that post-translationally inhibits P-gp ATPase efflux activity. P-gp inhibition is conserved in the Eggerthellaceae family but absent in other Actinobacteria. Comparative genomics identified genes associated with P-gp inhibition. Finally, activity-guided biochemical fractionation coupled to metabolomics implicated a group of small polar metabolites with P-gp inhibitory activity. These results highlight the importance of considering the broader relevance of the gut microbiome for drug disposition beyond first-pass metabolism. Competing Interests: P.J.T. is on the scientific advisory boards for Pendulum, Seres, and SNIPR Biome; there is no direct overlap between the current study and these consulting duties. (© 2024 The Author(s).) |
References: | Am J Physiol Gastrointest Liver Physiol. 2012 Jul;303(1):G32-41. (PMID: 22538402) Methods Mol Biol. 2017;1472:105-10. (PMID: 27671935) Bioinformatics. 2019 Feb 1;35(3):526-528. (PMID: 30016406) Science. 2019 Jun 14;364(6445):. (PMID: 31196984) Science. 2001 Feb 2;291(5505):881-4. (PMID: 11157169) Cell. 2020 Jun 25;181(7):1661-1679.e22. (PMID: 32526207) Chem Rev. 1996 Nov 7;96(7):2757-2816. (PMID: 11848841) Science. 2013 Jul 19;341(6143):295-8. (PMID: 23869020) Nat Rev Microbiol. 2016 Apr;14(5):273-87. (PMID: 26972811) Nat Genet. 2007 Apr;39(4):426. (PMID: 17392795) Microbiome. 2021 Sep 7;9(1):183. (PMID: 34493329) Nature. 2019 Jun;570(7762):462-467. (PMID: 31158845) Nat Methods. 2015 Jun;12(6):523-6. (PMID: 25938372) Nat Commun. 2022 Dec 9;13(1):7624. (PMID: 36494336) Cancer Chemother Pharmacol. 2010 Sep;66(4):765-71. (PMID: 20041327) Front Microbiol. 2020 Dec 11;11:615860. (PMID: 33362753) Am J Physiol Gastrointest Liver Physiol. 2011 Jun;300(6):G1115-23. (PMID: 21350189) Drug Metab Dispos. 2017 Dec;45(12):1225-1238. (PMID: 28939687) Cell. 2022 Sep 15;185(19):3617-3636.e19. (PMID: 36070752) Cell Host Microbe. 2019 Jul 10;26(1):22-34. (PMID: 31295421) PLoS One. 2009 Oct 12;4(10):e7415. (PMID: 19823672) Clin Pharmacol Ther. 2022 Sep;112(3):443-445. (PMID: 35668713) J Biol Chem. 1996 Feb 2;271(5):2557-62. (PMID: 8576221) Science. 2019 Dec 13;366(6471):. (PMID: 31582523) Proc Natl Acad Sci U S A. 2020 Jul 7;117(27):16009-16018. (PMID: 32571913) Elife. 2018 May 15;7:. (PMID: 29761785) Am J Physiol Gastrointest Liver Physiol. 2008 Jun;294(6):G1392-400. (PMID: 18403618) Nucleic Acids Res. 2022 Jan 7;50(D1):D622-D631. (PMID: 34986597) Cell Host Microbe. 2020 Jun 10;27(6):1001-1013.e9. (PMID: 32348781) Clin Pharmacokinet. 2020 Jun;59(6):699-714. (PMID: 32052379) Microbiome. 2023 Jul 6;11(1):138. (PMID: 37408070) Cell Host Microbe. 2022 Jan 12;30(1):17-30.e9. (PMID: 34822777) Br J Cancer. 2014 Jun 10;110(12):2896-904. (PMID: 24853187) PLoS Biol. 2023 May 19;21(5):e3002125. (PMID: 37205710) Sci Transl Med. 2009 Nov 11;1(6):6ra14. (PMID: 20368178) Nat Microbiol. 2020 Jan;5(1):56-66. (PMID: 31686027) Biochem Pharmacol. 2016 Oct 15;118:96-108. (PMID: 27531061) Science. 1983 Apr 15;220(4594):325-7. (PMID: 6836275) Gut. 2012 Aug;61(8):1124-31. (PMID: 22115825) Elife. 2020 Feb 18;9:. (PMID: 32067637) Drug Metab Dispos. 2018 Nov;46(11):1588-1595. (PMID: 30111623) Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. (PMID: 29126136) |
فهرسة مساهمة: | Keywords: Biological sciences; Microbiology; Microbiome; Natural sciences; Pharmacology |
تواريخ الأحداث: | Date Created: 20240701 Latest Revision: 20240702 |
رمز التحديث: | 20240702 |
مُعرف محوري في PubMed: | PMC11214321 |
DOI: | 10.1016/j.isci.2024.110122 |
PMID: | 38947502 |
قاعدة البيانات: | MEDLINE |
كن أول من يترك تعليقا!